sorafenib has been researched along with Carcinoma, Papillary, Follicular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busaidy, NL; Cabanillas, ME; Cote, GJ; Dadu, R; Devine, C; Habra, MA; Hernandez, M; Hu, MI; Jimenez, C; Sellin, RV; Sherman, SI; Waguespack, SG; Ying, AK | 1 |
| Abdulrahman, RM; Corssmit, EP; Kapiteijn, E; Morreau, H; Schneider, TC; Smit, JW | 1 |
1 trial(s) available for sorafenib and Carcinoma, Papillary, Follicular
| Article | Year |
|---|---|
Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Aged; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Carcinoma; Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Thyroglobulin; Thyroid Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
1 other study(ies) available for sorafenib and Carcinoma, Papillary, Follicular
| Article | Year |
|---|---|
Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary, Follicular; Chemotherapy, Adjuvant; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Molecular Targeted Therapy; Neoadjuvant Therapy; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Retrospective Studies; Salvage Therapy; Sorafenib; Thyroid Neoplasms; Treatment Failure | 2014 |